Ray MD - Search Results

1

Don't keep me waiting: estimating the lifetime impact of reduced vein-to-vein time for CAR-T treated patients with LBCL.

Vadgama S, Maziarz RT, Pasquini MC, Hu ZH, Ray MD, Smith H, Bullement A, Edmondson-Jones M, Sullivan W, Cartron G. Vadgama S, et al. Among authors: ray md. Blood Adv. 2024 Apr 25:bloodadvances.2023012240. doi: 10.1182/bloodadvances.2023012240. Online ahead of print. Blood Adv. 2024. PMID: 38662645

2

Network meta-analysis of CAR T-Cell therapy for the treatment of 3L+ R/R LBCL after using published comparative studies.

Oluwole OO, Neelapu SS, Ray MD, Limbrick-Oldfield EH, Wade SW, Kanters S, Patel AR, Locke FL. Oluwole OO, et al. Among authors: ray md. Expert Rev Anticancer Ther. 2024 Apr 24:1-9. doi: 10.1080/14737140.2024.2343801. Online ahead of print. Expert Rev Anticancer Ther. 2024. PMID: 38646700 Review.

3

Cost-effectiveness of axicabtagene ciloleucel for adult patients with relapsed or refractory follicular lymphoma in the United States.

Oluwole OO, Ray MD, Rosettie KL, Ball G, Jacob J, Bilir SP, Patel AR, Jacobson CA. Oluwole OO, et al. Among authors: ray md. Value Health. 2024 Apr 17:S1098-3015(24)02334-9. doi: 10.1016/j.jval.2024.04.003. Online ahead of print. Value Health. 2024. PMID: 38641058

4

Comparison of lung aeration loss in open abdominal oncologic surgeries after ventilation with electrical impedance tomography-guided PEEP versus conventional PEEP: a pilot feasibility study.

Karthik AR, Gupta N, Garg R, Bharati SJ, Ray MD, Hadda V, Pahuja S, Mishra S, Bhatnagar S, Kumar V. Karthik AR, et al. Among authors: ray md. Korean J Anesthesiol. 2024 Mar 5. doi: 10.4097/kja.23858. Online ahead of print. Korean J Anesthesiol. 2024. PMID: 38438222 Free article.

5

A Comparison of 3-Year Follow-up of ZUMA-5 (Axicabtagene Ciloleucel) With SCHOLAR-5 in Relapsed/Refractory Follicular Lymphoma.

Ghione P, Palomba ML, Ray MD, Limbrick-Oldfield EH, Owen J, Kanters S, Bobillo S, Ribiero MT, Jacobson CA, Neelapu SS, Ghesquieres H, Nahas M, Beygi S, Patel AR, Gribben JG. Ghione P, et al. Among authors: ray md. Clin Lymphoma Myeloma Leuk. 2024 May;24(5):e191-e195.e6. doi: 10.1016/j.clml.2024.01.011. Epub 2024 Jan 24. Clin Lymphoma Myeloma Leuk. 2024. PMID: 38365528

6

Cost-effectiveness of axicabtagene ciloleucel versus tisagenlecleucel for the treatment of 3L + relapsed/refractory large B-cell lymphoma in the United States: incorporating longer survival results.

Oluwole OO, Ray MD, Davies N, Bradford R, Jones C, Patel AR, Locke FL. Oluwole OO, et al. Among authors: ray md. J Med Econ. 2024 Jan-Dec;27(1):230-239. doi: 10.1080/13696998.2024.2305558. Epub 2024 Feb 13. J Med Econ. 2024. PMID: 38240256 Free article.

7

Can EPIC Be a Low-Cost Alternative to HIPEC in Advanced Epithelial Ovarian Cancer in Resource-Constraint Settings? Experience from Tertiary Care Oncology Center.

Talluri SH, Ray MD, N P, Kumar L, Garg R, Deo S. Talluri SH, et al. Among authors: ray md. Indian J Surg Oncol. 2023 Jun;14(Suppl 1):250-256. doi: 10.1007/s13193-023-01743-7. Epub 2023 May 30. Indian J Surg Oncol. 2023. PMID: 37359930

8

Pattern of Care in Real-World Scenario on Advanced Epithelial Ovarian Cancer in a Tertiary Referral Oncology Centre in India - ISPSM Collaborative Study.

Deo SVS, Ray MD, Kumar L, Khuranna S, Pramanik R, Mishra A, Bansal B, N P, Bhatnagar S, Garg R, Kumar V. Deo SVS, et al. Among authors: ray md. Indian J Surg Oncol. 2023 Jun;14(Suppl 1):233-239. doi: 10.1007/s13193-023-01746-4. Epub 2023 May 18. Indian J Surg Oncol. 2023. PMID: 37359919

9

Does the Nightmare of Distressing Complications of Groin Dissection Over with "River Flow" Incision? - Experience of 240 Dissections from Tertiary Referral Oncology Centre, India.

Ray MD, Josephin JRJ, N P. Ray MD, et al. Gulf J Oncolog. 2023 May;1(42):53-760. Gulf J Oncolog. 2023. PMID: 37283261

10

A prospective study evaluating perioperative quality metrics of cancer surgery: Experience from a tertiary care cancer centre in India.

Gupta P, Deo S, Ray MD, Kumar S, Khan MA, Bhatnagar S, Mishra S. Gupta P, et al. Among authors: ray md. J Surg Oncol. 2023 Aug;128(2):385-392. doi: 10.1002/jso.27278. Epub 2023 Apr 10. J Surg Oncol. 2023. PMID: 37036186

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

76 results

Search Page